Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,410 | 1,176 | 98.2% |
| Education | $252.38 | 6 | 1.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $111.45 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,825 | 115 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,663 | 97 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $1,160 | 50 | $0 (2024) |
| Amgen Inc. | $1,096 | 53 | $0 (2022) |
| ABBVIE INC. | $986.48 | 55 | $0 (2024) |
| Allergan, Inc. | $914.66 | 60 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $767.98 | 55 | $0 (2022) |
| Lilly USA, LLC | $725.51 | 44 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $714.64 | 68 | $0 (2020) |
| GENZYME CORPORATION | $637.33 | 33 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,468 | 123 | ABBVIE INC. ($296.52) |
| 2023 | $2,546 | 127 | UCB, Inc. ($373.76) |
| 2022 | $2,688 | 155 | ABBVIE INC. ($364.19) |
| 2021 | $2,725 | 145 | UCB, Inc. ($278.41) |
| 2020 | $2,452 | 141 | Amgen Inc. ($346.00) |
| 2019 | $3,244 | 202 | Novartis Pharmaceuticals Corporation ($485.57) |
| 2018 | $2,597 | 161 | Novartis Pharmaceuticals Corporation ($306.98) |
| 2017 | $2,055 | 135 | UCB, Inc. ($215.15) |
All Payment Transactions
1,189 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: EPILEPSY | ||||||
| 12/10/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: PAIN | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Central Nervous System | ||||||
| 11/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.53 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/02/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: PAIN | ||||||
| 10/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Analgesic | ||||||
| 10/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/28/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: EPILEPSY | ||||||
| 10/22/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological), INBRIJA | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Musculoskeletal | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,195 | 1,965 | $1.2M | $268,526 |
| 2022 | 15 | 1,447 | 2,269 | $710,784 | $268,223 |
| 2021 | 15 | 1,494 | 2,227 | $706,514 | $270,749 |
| 2020 | 14 | 1,424 | 2,183 | $857,857 | $245,761 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 442 | 1,004 | $279,875 | $88,584 | 31.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 134 | 139 | $121,200 | $45,203 | 37.3% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 16 | 48 | $336,000 | $29,829 | 8.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 191 | 191 | $69,350 | $22,241 | 32.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 122 | 287 | $74,775 | $21,495 | 28.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 27 | 27 | $32,400 | $12,408 | 38.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 76 | 82 | $38,675 | $12,273 | 31.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 62 | 62 | $29,925 | $11,417 | 38.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 12 | 12 | $16,100 | $5,773 | 35.9% |
| 95712 | Measurement of brain wave activity with video (veeg), 2-12 hours with intermittent monitoring | Office | 2023 | 17 | 17 | $42,500 | $5,665 | 13.3% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Office | 2023 | 16 | 16 | $24,000 | $3,930 | 16.4% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 17 | 17 | $85,000 | $2,998 | 3.5% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 11 | 11 | $6,600 | $1,836 | 27.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 19 | 19 | $4,750 | $1,453 | 30.6% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 11 | 11 | $6,600 | $1,424 | 21.6% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 11 | 11 | $1,650 | $1,069 | 64.8% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 11 | 11 | $2,750 | $926.42 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 473 | 1,021 | $245,100 | $90,558 | 36.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 138 | 140 | $109,040 | $46,727 | 42.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 173 | 402 | $94,000 | $31,402 | 33.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 128 | 136 | $56,975 | $25,370 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 200 | 200 | $69,644 | $22,526 | 32.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 33 | 33 | $39,500 | $15,192 | 38.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 63 | 66 | $27,200 | $10,691 | 39.3% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2022 | 36 | 36 | $23,400 | $7,160 | 30.6% |
About Dr. George Wang, M.D
Dr. George Wang, M.D is a Neurology healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851342828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Wang, M.D has received a total of $20,774 in payments from pharmaceutical and medical device companies, with $2,468 received in 2024. These payments were reported across 1,189 transactions from 80 companies. The most common payment nature is "Food and Beverage" ($20,410).
As a Medicare-enrolled provider, Wang has provided services to 5,560 Medicare beneficiaries, totaling 8,644 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Mesa, AZ
- Active Since 05/15/2006
- Last Updated 12/19/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1851342828
Products in Payments
- Briviact (Drug) $1,112
- Aimovig (Biological) $1,024
- BOTOX (Biological) $995.08
- APTIOM (Drug) $925.33
- NURTEC ODT (Drug) $868.36
- TROKENDI XR (Drug) $637.48
- AIMOVIG (Biological) $605.42
- AUBAGIO (Drug) $585.80
- ACTHAR (Biological) $568.58
- XYWAV (Drug) $568.38
- EMGALITY (Drug) $523.29
- KESIMPTA (Drug) $507.07
- Neupro (Drug) $456.26
- VYEPTI (Biological) $382.68
- GILENYA (Drug) $368.82
- UBRELVY (Drug) $346.62
- Wakix (Drug) $340.14
- MIGRANAL (Drug) $311.53
- QULIPTA (Drug) $304.29
- RYTARY (Drug) $298.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Mesa
Dr. Mohamed Teleb, M.d, M.D
Neurology — Payments: $180,073
Dr. David Marzulo, D.o, D.O
Neurology — Payments: $47,034
Gilbert Toffol, D.o, D.O
Neurology — Payments: $43,756
Dr. Jaime Rawson, D.o, D.O
Neurology — Payments: $21,250
Catherine Kapoor, Md, MD
Neurology — Payments: $18,238
Dr. Julius Charlie, M.d, M.D
Neurology — Payments: $17,418